Realtime | Geld | Brief | Zeit |
---|---|---|---|
1,300 | 1,460 | 12:00 | |
1,350 | 1,410 | 11:44 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | NanoViricides Measles Drug Development Animal Study is Imminent | 287 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum... ► Artikel lesen | |
28.05. | NanoViricides to Present at the BIO International Convention in Boston on Monday, June 16, 2025 | 566 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / May 28, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus... ► Artikel lesen | |
22.05. | The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides' Dr. Diwan | 478 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the "Company"), comments on the new COVID Vaccine policy adopted by the US FDA.The... ► Artikel lesen | |
16.05. | NanoViricides GAAP EPS of -$0.14 | 7 | Seeking Alpha | ||
16.05. | NanoViricides, Inc. Has Filed its Quarterly Report: Broad-Spectrum Antiviral NV-387 To Combat MPox Pandemic in Africa - Phase II Clinical Trial Update, Also Readying to Combat Measles Outbreaks, and to Tackle Bird Flu | 568 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / May 16, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending March 31, 2025... ► Artikel lesen | |
NANOVIRICIDES Aktie jetzt für 0€ handeln | |||||
15.05. | NANOVIRICIDES, INC. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
14.05. | NanoViricides: Measles Cases Are Increasing Globally; MPox Continues to Be a Threat - Broad-Spectrum Antiviral Drug Could Be the Solution | 559 | ACCESS Newswire | NanoViricides Explains Its Drug Strategy for Combating Viral Infections and Pandemics SHELTON, CT / ACCESS Newswire / May 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC)... ► Artikel lesen | |
08.05. | NanoViricides: Broad-Spectrum Antiviral Drug NV-387 Cleared for Phase II Clinical Trial Application by the National Ethics Committee of the Democratic Republic of Congo | 590 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / May 8, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company") today reported that it has received approval from the National Ethics Committee for Health (CNES)... ► Artikel lesen | |
05.05. | D.Boral Capital: NanoViricides, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference, May 14th, NYC | 603 | Newsfile | Shelton, Connecticut--(Newsfile Corp. - May 5, 2025) - NanoViricides, Inc. (NYSE American: NNVC), (the "Company"), a leading clinical stage global pioneer in the development of broad-spectrum antivirals... ► Artikel lesen | |
29.04. | Measles is Likely to Become Endemic - NanoViricides Is Testing a Drug to Combat It | 494 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / April 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a leading global pioneer in the development of broad-spectrum antivirals... ► Artikel lesen | |
14.04. | Measles Outbreak Expands Begging for a Drug to Treat the Infection - NanoViricides Declares it is Ready to Fight the Outbreak | 659 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / April 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a leading global pioneer in the development of broad-spectrum antivirals... ► Artikel lesen | |
11.03. | NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company | 909 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / March 11, 2025 / NanoViricides, Inc. (the "Company")(NYSE American:NNVC), a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that... ► Artikel lesen | |
04.03. | Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan | 744 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / March 4, 2025 / The HHS Department Secretary Robert F. Kennedy Jr. wrote an Opinion piece in the FoxNews entitled "Measles outbreak is call to action for all of us".... ► Artikel lesen | |
19.02. | NanoViricides GAAP EPS of -$0.14 | 2 | Seeking Alpha | ||
19.02. | NanoViricides, Inc. Has Filed its Quarterly Report | 659 | ACCESS Newswire | Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu SHELTON, CT / ACCESS Newswire / February 19, 2025 / NanoViricides, Inc. (NYSE... ► Artikel lesen | |
14.02. | NANOVIRICIDES, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
11.02. | NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape | 803 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum... ► Artikel lesen | |
29.01. | NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025 | 817 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / January 29, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the... ► Artikel lesen | |
27.01. | NanoViricides Engages CRO for Phase II Clinical Trial | 1.038 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / January 27, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase... ► Artikel lesen | |
13.01. | NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025 | 613 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / January 13, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 27,600 | +5,34 % | Kursverluste für die Aktie von Formycon (23,50 €) | Das Wertpapier von Formycon notiert heute leichter. Der jüngste Kurs betrug 23,50 Euro. An der deutschen Börse hat sich heute die Formycon-Aktie zwischenzeitlich um 0,84 Prozent verbilligt. Der Kurs... ► Artikel lesen | |
GAUZY | 7,620 | 0,00 % | GAUZY LTD: Gauzy Announces Minimal to No Impact on Business with Its U.S. Customers Amid United States New Tariff Policy on Imports | Gauzy's Long-Established 20,000 SqFt Production Facility in Florida, Originally Designated to Support U.S. Aeronautics Customers, Already Serves All Company Divisions, Including Architecture, Automotive... ► Artikel lesen | |
ONTO INNOVATION | 84,50 | 0,00 % | EQS-Media: LPKF Laser & Electronics SE: Onto Innovation und LPKF treiben gemeinsam die Massenproduktion von Glassubstraten für Halbleiter voran | EQS-Media / 02.04.2025 / 09:00 CET/CEST
Onto Innovation und LPKF treiben gemeinsam die Massenproduktion von Glassubstraten für Halbleiter voran
LPKF schließt sich dem Packaging Applications... ► Artikel lesen | |
KOPIN | 1,239 | -0,72 % | Kopin Corp. CFO Rich Sneider To Retire | WASHINGTON (dpa-AFX) - Kopin Corporation (KOPN) Thursday said its Chief Financial Officer, Rich Sneider is retiring, and has commenced a search to find a replacement.Sneider is expected to remain... ► Artikel lesen | |
DOTZ NANO | 0,026 | -3,70 % | DOTZ NANO LIMITED: Cleansing Statement | ||
VEECO INSTRUMENTS | 17,900 | 0,00 % | Veeco Instruments Inc.: Veeco Updates Fourth Quarter and Full Year 2024 Guidance | PLAINVIEW, N.Y., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ: VECO) today has updated its financial guidance for the fourth quarter and full year 2024. We expect revenue for... ► Artikel lesen | |
FENDX TECHNOLOGIES | 0,050 | +19,71 % | FendX Technologies Inc.: FendX Announces Share Issuance Pursuant to IP License Agreement | Oakville, Ontario--(Newsfile Corp. - May 5, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection... ► Artikel lesen | |
NVE | 63,50 | +0,79 % | Dividendenbekanntmachungen (19.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AFFILIATED MANAGERS GROUP INC US0082521081 0,01 USD 0,0089 EUR AIR LIQUIDE SA FR0000120073 - 3,3 EUR ALA SPA IT0005446700 - 0,75... ► Artikel lesen | |
OBDUCAT | 0,045 | +12,50 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
ACACIA RESEARCH | 3,180 | -1,85 % | ACACIA RESEARCH CORP - 8-K, Current Report | ||
ADVANCE ZINCTEK | 0,430 | +0,47 % | ADVANCE ZINCTEK LIMITED: Business Update | ||
LEHNER INVESTMENTS | 0,030 | +20,00 % | EQS-Adhoc: LEHNER INVESTMENTS AG: Sonderprüfung gerichtlich angeordnet | EQS-Ad-hoc: LEHNER INVESTMENTS AG / Schlagwort(e): Rechtssache
LEHNER INVESTMENTS AG: Sonderprüfung gerichtlich angeordnet
04.04.2025 / 18:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
NANOFOCUS | 1,400 | 0,00 % | EQS-Adhoc: NanoFocus AG: Carl Mahr Holding GmbH übermittelt Übertragungsverlangen hinsichtlich der Aktien der Minderheitsaktionäre der NanoFocus AG (aktienrechtlicher Squeeze-out) | EQS-Ad-hoc: NanoFocus AG / Schlagwort(e): Squeeze-Out
NanoFocus AG: Carl Mahr Holding GmbH übermittelt Übertragungsverlangen hinsichtlich der Aktien der Minderheitsaktionäre der NanoFocus... ► Artikel lesen | |
RIBER | 2,755 | -0,72 % | Riber receives order from Asia for MBE 412 research system | ||
GOMSPACE | 1,256 | -4,27 % | GomSpace Group AB: GomSpace reports positive net profit in Q1 2025 | GomSpace releases its Q1 2025 trading statement and reports a strong revenue growth, positive operational EBITDA and a positive net profit in the first quarter.
FIRST QUARTER OF 2025
Order intake... ► Artikel lesen |